Drug archive
Abciximab (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antithrombotic
- Monoclonal antibody (antithrombotic)
- Platelet aggregation inhibitor
Description
Abciximab(ab-SIKS-ih-mab) is used to lessen the chance of heart attack in people who need percutaneous coronary intervention (PCI), a procedure to open blocked arteries of the heart.
A heart attack may occur when a blood vessel in the heart is blocked by a blood clot. Blood clots can sometimes form during PCI. Abciximab reduces the chance that a harmful clot will form by preventing certain cells in the blood from clumping together. Abciximab is used with aspirin and heparin, which are other medicines used to keep your blood from clotting.
This medicine is available only with your doctor's prescription, in the following dosage forms:
- Injection (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- ReoPro
In Canada -
- ReoPro
Other commonly used names are
c7E3 Fab